Findings

What do systematic reviews say?

3 questions · 3 findings · 2 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 2 · 66.7%Low 1 · 33.3%Moderate 0 · 0%High 0 · 0%

Oral ferric maltol vs oral placebo

Serious adverse events ‐ mild disease to quiescent (up to 52 weeks) · IBD patients

It is very uncertain whether oral ferric maltol changes serious adverse events ‐ mild disease to quiescent (up to 52 weeks) compared with oral placebo (very low certainty).

1 finding from 1 review

Interventions for treating iron deficiency anaemia in inflammatory bowel disease 2021 · Cochrane Headline outcomes only
RR 1 [0.15, 6.88]
1 study · 128 participants
Very low

Oral ferric maltol vs IV ferric carboxymaltose

Serious adverse events (12 weeks) · IBD patients

It is very uncertain whether oral ferric maltol changes serious adverse events (12 weeks) compared with IV ferric carboxymaltose (very low certainty).

1 finding from 1 review

Interventions for treating iron deficiency anaemia in inflammatory bowel disease 2021 · Cochrane Headline outcomes only
RR 2.95 [0.98, 8.91]
1 study · 252 participants
Very low

Oral propranolol vs placebo

Adverse events experienced at short or long term ‐ Serious adverse events 24 weeks' · infantile haemangiomas (strawberry birthmarks) of the skin

Oral propranolol showed no clear difference in adverse events experienced at short or long term ‐ Serious adverse… compared with placebo (low certainty).

1 finding from 1 review

Interventions for infantile haemangiomas of the skin 2018 · Cochrane Headline outcomes only
RR 1.05 [0.33, 3.39]
3 studies · 509 participants
Low